Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
about
Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignJC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and NeutralizationIdentification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 ProteinHepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral GenotypesHuman monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolateCharacterization of Anti-HCV Antibodies in IL-10-Treated PatientsNeutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoproteinChimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.Multiantibody strategies for HIV.Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies.
P2860
Q26801759-75CD8819-CA8D-4B26-ABAA-8DF5C3146832Q26852060-A2BBA841-58BC-4442-A43A-70DC3CFA9055Q27481012-1C65A6C5-2795-4E35-B08D-ABA42B2A8575Q27485318-57B2D501-C640-40F7-B9F0-9E21E89650C0Q27490450-DE0FA4A7-FF64-406B-9083-75878F85DD11Q28482261-FEBA2F58-F6FA-4589-9B4A-FAFF9EFF7412Q34296870-C41B5EA7-1DCF-4E1F-82EA-F786E758050BQ36404194-5B78090B-6CE4-484F-8AE2-97BEF7337268Q36432725-58563E4A-92CA-4EB1-885C-1D240E9A4DB5Q36506935-E553CF5B-0A10-4085-9EAD-8086A4324D7CQ36682313-91152C38-3EDF-4F6F-AEC8-CCBBB922407EQ38120526-659C3681-4B8C-415A-8129-F096F8D1C8BAQ38128299-C1F0CED0-A689-44B4-8FF9-B817BC2D13D7
P2860
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cross-reactive pseudovirus-neu ...... t hepatitis C virus infection.
@en
Cross-reactive pseudovirus-neu ...... t hepatitis C virus infection.
@nl
type
label
Cross-reactive pseudovirus-neu ...... t hepatitis C virus infection.
@en
Cross-reactive pseudovirus-neu ...... t hepatitis C virus infection.
@nl
prefLabel
Cross-reactive pseudovirus-neu ...... t hepatitis C virus infection.
@en
Cross-reactive pseudovirus-neu ...... t hepatitis C virus infection.
@nl
P2093
P50
P1433
P1476
Cross-reactive pseudovirus-neu ...... nt hepatitis C virus infection
@en
P2093
Antonella Grieco
Mario Perotti
Roberto Burioni
Silvia Carletti
P304
P356
10.1016/J.VIROL.2004.06.042
P407
P577
2004-10-01T00:00:00Z